Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2023-11-06 Transaction in Own Shar…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Issue and repurchase of class C shares for incentive program
Transaction in Own Shares Classification · 1% confidence The document is a press release dated November 6, 2023, announcing the 'ISSUE AND REPURCHASE OF CLASS C SHARES FOR INCENTIVE PROGRAM'. This action involves the company issuing and immediately repurchasing shares as part of its long-term incentive programs. This directly relates to changes in the company's share structure and capital management, specifically share repurchase activities. Based on the definitions, 'Transaction in Own Shares (Code: POS)' covers the report of the company buying back or selling its own shares (share repurchase/issuance). While 'Capital/Financing Update (CAP)' is related, 'POS' is more specific to the described action of issuing and repurchasing shares for incentive plans.
2023-11-06 English
Emission och återköp av C-aktier för incitamentsprogram
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated November 6, 2023, detailing a decision by the Board of Directors of Medicover AB (publ) to issue and immediately repurchase C-shares for incentive programs. This action involves the issuance of new shares and the subsequent repurchase of those shares, which directly relates to changes in the company's capital structure and share count. This aligns precisely with the definition for 'Share Issue/Capital Change' (SHA) or 'Transaction in Own Shares' (POS). Since the primary action described is the issuance of new shares followed by a repurchase to fulfill incentive plans, SHA (Share Issue/Capital Change) is the most fitting primary category, although POS (Transaction in Own Shares) is also highly relevant. Given the context of issuing shares specifically for incentive programs, SHA is chosen as the broader capital structure event. The document is a direct announcement, not a report announcement (RPA).
2023-11-06 Swedish
Joe Ryan to retire as Medicover Chief Financial Officer in 2024
Board/Management Information Classification · 1% confidence The document is a short press release announcing a specific change in senior personnel: the retirement of the Chief Financial Officer (CFO), Joe Ryan, and the initiation of a search for a successor. This directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2023-11-03 English
Joe Ryan, CFO, lämnar Medicover och går i pension under 2024
Board/Management Information Classification · 1% confidence The document is a press release (Pressmeddelande) dated November 3, 2023, announcing that the Chief Financial Officer (CFO), Joe Ryan, is leaving the company (Medicover) to retire in 2024. This constitutes an announcement of a change in senior management. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category.
2023-11-03 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT JULI–SEPTEMBER 2023' (Interim Report July-September 2023) and contains comprehensive financial statements, performance metrics (EBIT, EBITDA, Nettoomsättning), and management commentary for the third quarter and the first nine months of the year. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. Q3 2023
2023-11-03 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JULY–SEPTEMBER 2023' and contains detailed financial statements, including revenue, operating profit, EBITDA, and cash flow metrics for the third quarter and nine-month period. It includes a CEO statement, operational highlights, and comparative tables. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2023
2023-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.